Dyspepsia differential diagnosis
Jump to navigation
Jump to search
|
Dyspepsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dyspepsia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Dyspepsia differential diagnosis |
|
Risk calculators and risk factors for Dyspepsia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]
Overview
Symptoms cannot reliably separate organic from functional dyspepsia, and no single history finding, examination finding, or biomarker distinguishes them. The differential diagnosis is therefore approached in three steps: exclude a limited set of organic mimics, keep myocardial ischemia in mind as the can't-miss extra-luminal cause, and then apply Rome IV criteria to diagnose functional dyspepsia (FD).[1] About 80% of patients with dyspepsia have no clinically significant finding at endoscopy. Fewer than 10% have peptic ulcer, and fewer than 0.5% have gastro-esophageal malignancy, so the pretest probability strongly favors FD.[2] FD must then be distinguished from other disorders of gut–brain interaction (DGBI) and from the chronic nausea and vomiting disorders it overlaps with.[3]
Differentiating Dyspepsia from other Diseases
Organic Mimics
The organic mimics below are listed in descending order of frequency in Europe and North America.[1] For drug-induced dyspepsia, see causes.
| Disorder | Discriminating features | Best confirmatory test |
|---|---|---|
| Gastroesophageal reflux disease (GERD) | Heartburn or regurgitation predominates. GERD coexists with FD in a large proportion of patients (>30% of FD patients report GERD symptoms; >40% of GERD patients report FD symptoms) and does not exclude FD. Meal-related epigastric pain or burning is more often FD than GERD.[4][3][5] | Endoscopy (erosive esophagitis); off-PPI ambulatory pH or pH-impedance monitoring; empiric PPI trial |
| Drug-induced dyspepsia | Symptoms are temporally linked to NSAIDs or aspirin, which have the best evidence. Other implicated drugs include iron, calcium channel blockers, ACE inhibitors, methylxanthines, glucocorticoids, and tetracyclines or erythromycin. | Resolution after withdrawal |
| Peptic ulcer disease (± Helicobacter pylori) | Episodic epigastric pain. Peptic ulcer is the only endoscopic finding significantly more common in dyspeptic than non-dyspeptic individuals (OR 2.07).[2] | Endoscopy; non-invasive H. pylori testing[6] |
| Symptomatic biliary disease (gallstones, sphincter of Oddi dysfunction, biliary dyskinesia, gallbladder cancer) | Episodic RUQ or epigastric pain, often postprandial or nocturnal, that may radiate to the back or scapula | Abdominal ultrasound; CCK-stimulated HIDA scan showing a reduced gallbladder ejection fraction (typically <40%) supports functional gallbladder disorder |
| Gastroduodenal Crohn's disease | Diarrhea, weight loss, systemic inflammation; aphthous or cobblestone mucosa | Endoscopy with biopsy; cross-sectional enterography |
| Gastro-esophageal malignancy | Older age, dysphagia, alarm features. Rare (<0.5%), but it is the reason for age- and alarm-based endoscopy.[2] | Endoscopy with biopsy[7] |
| Gastroparesis | Nausea, vomiting, and weight loss are more prominent. Overlaps heavily with FD (see below). | 4-hour solid-phase gastric emptying scintigraphy[8] |
| Hepatocellular carcinoma | Chronic liver disease, weight loss, RUQ mass | Multiphasic CT or MRI; AFP |
| Chronic pancreatitis / pancreatic cancer | Epigastric pain radiating to the back, weight loss, new-onset diabetes, steatorrhea, jaundice | CT, MRI, or EUS; fecal elastase[9] |
| Parasitic infection (Giardia, Strongyloides, anisakiasis) | Travel or exposure history, diarrhea, eosinophilia | Stool studies or serology; duodenal aspirate |
| Infiltrative disease (eosinophilic gastroenteritis, sarcoidosis, amyloidosis) | Atopy or peripheral eosinophilia (eosinophilic disease); systemic features | Endoscopy with biopsy |
| Chronic mesenteric ischemia | Postprandial pain ("intestinal angina"), food fear, weight loss, known vasculopathy | CT angiography or mesenteric duplex ultrasound |
Can't-Miss Extra-Luminal Cause: Myocardial Ischemia
Myocardial ischemia can present as epigastric pain that mimics dyspepsia, especially in women, older adults, and patients with diabetes. Symptoms alone do not reliably separate cardiac from gastrointestinal epigastric pain. The Fourth Universal Definition of Myocardial Infarction lists epigastric discomfort as a recognized ischemic symptom that overlaps with gastrointestinal complaints. Obtain an ECG and troponin in higher-risk patients, and whenever the pain is exertional or radiating or comes with diaphoresis or dyspnea.[10]
Age and Alarm Features
Age and alarm features determine who needs upper endoscopy before FD is diagnosed. Both thresholds have shifted from older teaching; see other diagnostic studies for details.
- Age ≥60 years: ACG/CAG recommends upper endoscopy to exclude neoplasia. This is a conditional recommendation based on very low-quality evidence.[9] ASGE uses a lower threshold of ≥50 years.[6] AGA has used ≥55 years.
- Age <60 years without alarm features: use non-invasive H. pylori test-and-treat. Urea breath test or stool antigen is preferred over serology. If the test is negative or symptoms persist, start an empiric PPI trial.[9]
- Alarm features: these include progressive dysphagia, unexplained weight loss, GI bleeding or iron-deficiency anemia, persistent vomiting, palpable mass or lymphadenopathy, jaundice, and family history of upper-GI cancer.
- Each alarm feature has a low positive predictive value for upper-GI malignancy.
- ACG/CAG does not recommend endoscopy in patients <60 years solely because an alarm feature is present.
- Decisions are individualized, for example when there is clinically significant weight loss, rapidly progressive dysphagia, or multiple alarm features.[9]
- Suspected pancreatic or biliary source (pain radiating to the back, jaundice): obtain ultrasound or CT rather than endoscopy alone.
| Dyspepsia (epigastric pain/burning, postprandial fullness, early satiety) | |||||||||||||||||||||||||||||
| Consider cardiac, biliary, pancreatic sources Stop NSAIDs/culprit drugs | |||||||||||||||||||||||||||||
| Age ≥60 yr Upper endoscopy | Age <60 yr H. pylori test-and-treat (alarm features: individualize) | ||||||||||||||||||||||||||||
| Negative or persistent symptoms Empiric PPI trial | |||||||||||||||||||||||||||||
| Organic cause identified? | |||||||||||||||||||||||||||||
| Yes: secondary (organic) dyspepsia Treat cause | No: functional dyspepsia (Rome IV: PDS, EPS, overlap) | ||||||||||||||||||||||||||||
Differentiating Functional Dyspepsia from other DGBI and Motility Disorders
Once organic disease is excluded, FD must be separated from adjacent DGBI and from chronic nausea and vomiting disorders. Under Rome IV, FD comprises postprandial distress syndrome, epigastric pain syndrome, or an overlap of the two.[3]
| Disorder | Features favoring the alternative diagnosis over FD | Diagnostic approach |
|---|---|---|
| Gastroparesis | Vomiting and weight loss favor gastroparesis, while epigastric pain or burning favors FD. The two conditions share early satiety, fullness, bloating, and epigastric pain. Delayed emptying occurs in approximately 18–30% of patients with FD-type symptoms (usually mild), and some gastroparesis patients empty normally; the two are increasingly viewed as a spectrum of gastric sensorimotor dysfunction rather than distinct diseases.[1][11][12] | Gastric emptying scintigraphy confirms delayed emptying but has limited discriminating value in typical FD.[8] |
| Irritable bowel syndrome | Lower-abdominal pain with altered bowel habit that is related to defecation. One third to one half of FD patients also meet IBS criteria; coexistence supports rather than refutes a DGBI diagnosis.[1][3] | Rome IV clinical criteria |
| Rumination syndrome | Effortless regurgitation of undigested food within minutes of eating, without retching | Clinical diagnosis; high-resolution impedance manometry if uncertain. Gastric emptying studies do not help. |
| Cyclic vomiting syndrome / cannabinoid hyperemesis syndrome | Stereotyped discrete vomiting episodes separated by symptom-free intervals. Recurrent vomiting is not consistent with FD. | Clinical criteria; cannabis use history |
| Eating disorders (anorexia nervosa, bulimia nervosa) | Disordered eating cognitions, purging, and signs such as lanugo or Russell's sign. Gastric emptying may be secondarily delayed. | Clinical and psychiatric assessment |
Clinically Actionable Recommendations
- Review and stop culprit drugs (NSAIDs, aspirin), and establish H. pylori status before further testing.[11]
- A complete blood count is reasonable because anemia changes the differential. Obtain liver tests when severe episodic epigastric pain suggests a hepatobiliary source. Routine amylase/lipase, thyroid tests, and celiac serology are not recommended because of low yield; see laboratory findings.[1][11]
- Reserve abdominal ultrasound or CT for suspected biliary or pancreatic disease; routine imaging has low yield.
- Use Carnett's sign to separate abdominal-wall pain from visceral pain (diagnostic accuracy >90% for chronic abdominal wall pain).[1]
- Do not reflexively relabel meal-related epigastric burning as GERD, because it is more often FD.[4]
Important Updates Compared With Older Teaching
- Age is the dominant predictor of malignancy. Alarm features have a low positive predictive value, and in patients <60 years they no longer automatically trigger endoscopy.[9]
- FD and gastroparesis are framed as a shared sensorimotor spectrum rather than mutually exclusive diagnoses.[3]
- Peptic ulcer is the only endoscopic finding enriched in dyspepsia versus controls. Erosive esophagitis is the most common finding but is similarly prevalent in non-dyspeptic individuals.[2]
Areas of Uncertainty and Controversy
- Endoscopy age threshold: the threshold differs across ASGE (50), AGA (55), and ACG/CAG (60), and should be lower in regions with high gastric cancer incidence.[9][6]
- FD–gastroparesis boundary: it remains debated whether delayed gastric emptying defines a distinct disease or a point on a continuum.[12]
- DGBI overlap: FD, IBS, GERD, and functional heartburn frequently coexist, which complicates any single-diagnosis differential.[1]
High-Yield Clinical Pearls
- About 80% of dyspepsia is functional, and symptoms cannot separate organic from functional disease.[1]
- Recurrent or persistent vomiting should prompt consideration of gastroparesis, gastric outlet obstruction, cyclic vomiting, or cannabinoid hyperemesis rather than FD.
- A positive Carnett's sign points to the abdominal wall and can spare an unnecessary GI workup.
Common Pitfalls
- Ordering endoscopy in a patient <60 years solely because of an isolated alarm feature
- Labeling meal-related epigastric burning as GERD
- Over-relying on gastric emptying studies to separate FD from gastroparesis
- Missing myocardial ischemia presenting as epigastric pain
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ (2020). "Functional dyspepsia". Lancet. 396 (10263): 1689–1702. doi:10.1016/S0140-6736(20)30469-4. PMID 33049222 Check
|pmid=value (help). - ↑ 2.0 2.1 2.2 2.3 Nasseri-Moghaddam S, Mousavian AH, Kasaeian A; et al. (2023). "What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Updated systematic review and meta-analysis". Clin Gastroenterol Hepatol. 21 (7): 1739–1749.e2. doi:10.1016/j.cgh.2022.05.041.
- ↑ 3.0 3.1 3.2 3.3 3.4 Pasricha PJ, Talley NJ (2026). "Functional dyspepsia". N Engl J Med. 394 (2): 166–176. doi:10.1056/NEJMcp2501860.
- ↑ 4.0 4.1 Richter JE, Rubenstein JH (2018). "Presentation and epidemiology of gastroesophageal reflux disease". Gastroenterology. 154 (2): 267–276. doi:10.1053/j.gastro.2017.07.045.
- ↑ Geeraerts A, Van Houtte B, Clevers E; et al. (2020). "Gastroesophageal reflux disease-functional dyspepsia overlap: do birds of a feather flock together?". Am J Gastroenterol. 115 (8): 1167–1182. doi:10.14309/ajg.0000000000000619.
- ↑ 6.0 6.1 6.2 Shaukat A, Wang A, Acosta RD; et al. (2015). "The role of endoscopy in dyspepsia". Gastrointest Endosc. 82 (2): 227–232. doi:10.1016/j.gie.2015.04.003.
- ↑ Patel AK, Sethi NS, Park H (2026). "Gastric cancer: a review". JAMA. 335 (5): 439–450. doi:10.1001/jama.2025.20034.
- ↑ 8.0 8.1 Shin A (2024). "Disorders of gastric motility". Lancet Gastroenterol Hepatol. 9 (11): 1052–1064. doi:10.1016/S2468-1253(24)00231-0.
- ↑ 9.0 9.1 9.2 9.3 9.4 9.5 Moayyedi P, Lacy BE, Andrews CN; et al. (2017). "ACG and CAG clinical guideline: management of dyspepsia". Am J Gastroenterol. 112 (7): 988–1013. doi:10.1038/ajg.2017.154.
- ↑ Thygesen K, Alpert JS, Jaffe AS; et al. (2018). "Fourth Universal Definition of Myocardial Infarction (2018)". J Am Coll Cardiol. 72 (18): 2231–2264. doi:10.1016/j.jacc.2018.08.1038.
- ↑ 11.0 11.1 11.2 Törnblom H, Carbone F, Hasler WL; et al. (2026). "Gastroduodenal disorders". Gastroenterology. 170 (6): 1240–1260. doi:10.1053/j.gastro.2026.01.038.
- ↑ 12.0 12.1 Huang IH, Schol J, Carbone F; et al. (2023). "Prevalence of delayed gastric emptying in patients with gastroparesis-like symptoms". Aliment Pharmacol Ther. 57 (7): 773–782. doi:10.1111/apt.17330.